Willi Sauerbrei
#138,474
Most Influential Person Now
Researcher
Willi Sauerbrei's AcademicInfluence.com Rankings
Willi Sauerbreicomputer-science Degrees
Computer Science
#6496
World Rank
#6849
Historical Rank
Information Technology
#44
World Rank
#45
Historical Rank
Data Science
#127
World Rank
#130
Historical Rank
Machine Learning
#2130
World Rank
#2158
Historical Rank

Willi Sauerbreimathematics Degrees
Mathematics
#6566
World Rank
#9071
Historical Rank
Statistics
#629
World Rank
#712
Historical Rank
Measure Theory
#1433
World Rank
#1798
Historical Rank

Download Badge
Computer Science Mathematics
Why Is Willi Sauerbrei Influential?
(Suggest an Edit or Addition)Willi Sauerbrei's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials (2005) (6940)
- Tamoxifen for early breast cancer: an overview of the randomised trials (1998) (3764)
- Reporting recommendations for tumor marker prognostic studies (REMARK). (2005) (2075)
- Dichotomizing continuous predictors in multiple regression: a bad idea (2006) (1866)
- Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. (1994) (1100)
- The use of fractional polynomials to model continuous risk variables in epidemiology. (1999) (1060)
- Multivariable Model-Building: A Pragmatic Approach to Regression Analysis based on Fractional Polynomials for Modelling Continuous Variables (2008) (807)
- Reporting recommendations for tumor marker prognostic studies. (2005) (787)
- Selection of important variables and determination of functional form for continuous predictors in multivariable model building (2007) (785)
- Assessment and comparison of prognostic classification schemes for survival data. (1999) (709)
- A bootstrap resampling procedure for model building: application to the Cox regression model. (1992) (597)
- REporting recommendations for tumour MARKer prognostic studies (REMARK) (2005) (543)
- Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration (2012) (536)
- REporting recommendations for tumor MARKer prognostic studies (REMARK) (2005) (534)
- A new measure of prognostic separation in survival data (2004) (395)
- Prognosis research strategy (PROGRESS) 4: Stratified medicine research (2013) (385)
- REporting recommendations for tumour MARKer prognostic studies (REMARK) (2006) (375)
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): Explanation and Elaboration (2012) (335)
- Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study. (2002) (334)
- Multivariable regression model building by using fractional polynomials: Description of SAS, STATA and R programs (2006) (317)
- The Use of Resampling Methods to Simplify Regression Models in Medical Statistics (1999) (315)
- Reporting Recommendations for Tumor Marker Prognostic Studies (REMARK): An Abridged Explanation and Elaboration (2018) (265)
- A new approach to modelling interactions between treatment and continuous covariates in clinical trials by using fractional polynomials (2004) (255)
- Multivariable Modeling with Cubic Regression Splines: A Principled Approach (2007) (218)
- A review of spline function procedures in R (2019) (216)
- Building Multivariable Regression Models with Continuous Covariates in Clinical Epidemiology (2005) (200)
- Multivariable model-building (2008) (194)
- REporting recommendations for tumour MARKer prognostic studies (REMARK). (2005) (189)
- Development and validation of diagnostic scores for atopic dermatitis incorporating criteria of data quality and practical usefulness. (1996) (163)
- Role of isolated locoregional recurrence of breast cancer: results of four prospective studies. (2000) (149)
- Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients. German Breast Cancer Study Group. (1994) (146)
- Resampling and cross-validation techniques: a tool to reduce bias caused by model building? (1997) (143)
- Development of the Instrument to assess the Credibility of Effect Modification Analyses (ICEMAN) in randomized controlled trials and meta-analyses (2020) (141)
- Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer. (2003) (137)
- Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond (2009) (132)
- Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines (2009) (122)
- Stability of multivariable fractional polynomial models with selection of variables and transformations: a bootstrap investigation (2003) (110)
- Sample size considerations for the evaluation of prognostic factors in survival analysis. (2000) (108)
- Multivariate Analysis of Prognostic Factors in Patients with Glioblastoma (2003) (102)
- Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF) (2003) (101)
- Stability Investigations of Multivariable Regression Models Derived from Low- and High-Dimensional Data (2011) (95)
- STRengthening Analytical Thinking for Observational Studies: the STRATOS initiative (2014) (94)
- Modelling the effects of standard prognostic factors in node-positive breast cancer (1999) (93)
- Confidence intervals for the effect of a prognostic factor after selection of an ‘optimal’ cutpoint (2004) (92)
- A New Proposal for Multivariable Modelling of Time‐Varying Effects in Survival Data Based on Fractional Polynomial Time‐Transformation (2007) (87)
- Identification of clinically useful cancer prognostic factors: what are we missing? (2005) (87)
- Comparison between splines and fractional polynomials for multivariable model building with continuous covariates: a simulation study with continuous response (2013) (84)
- State of the art in selection of variables and functional forms in multivariable analysis—outstanding issues (2019) (80)
- State of the art in selection of variables and functional forms in multivariable analysis—outstanding issues (2019) (80)
- Classification and regression trees (CART) used for the exploration of prognostic factors measured on different scales (1994) (79)
- Individual participant data meta-analysis of prognostic factor studies: state of the art? (2012) (77)
- Preoperative staging of breast cancer by palpation, mammography and high‐resolution ultrasound (1993) (76)
- Radiation therapy and tamoxifen after breast-conserving surgery: updated results of a 2 x 2 randomised clinical trial in patients with low risk of recurrence. (2010) (73)
- Tumor-cell number and viability as quality and efficacy parameters of autologous virus-modified cancer vaccines in patients with breast or ovarian cancer. (1997) (72)
- Radiation therapy after breast-conserving surgery; first results of a randomised clinical trial in patients with low risk of recurrence. (2004) (72)
- On the necessity and design of studies comparing statistical methods (2018) (67)
- Quality of life in goserelin-treated versus cyclophosphamide + methotrexate + fluorouracil-treated premenopausal and perimenopausal patients with node-positive, early breast cancer: the Zoladex Early Breast Cancer Research Association Trialists Group. (2003) (66)
- Duration of adjuvant chemotherapy for breast cancer: a joint analysis of two randomised trials investigating three versus six courses of CMF (2002) (64)
- Subsampling versus bootstrapping in resampling‐based model selection for multivariable regression (2016) (63)
- Color Doppler and duplex flow analysis for classification of breast lesions. (1997) (63)
- Added predictive value of high-throughput molecular data to clinical data and its validation (2011) (57)
- Color Doppler flow criteria of breast lesions. (1994) (57)
- Tumor-Cell Number and Viability as Quality and Efficacy Parameters of Autologous Virus-Modified Cancer Vaccines in Patients With Breast or Ovarian Cancer (1997) (56)
- Steroid receptors in ovarian carcinoma: immunohistochemical determination may lead to new aspects. (1992) (54)
- Improving the robustness of fractional polynomial models by preliminary covariate transformation: A pragmatic approach (2007) (54)
- Interactions between treatment and continuous covariates: a step toward individualizing therapy. (2008) (54)
- MFP: Multivariable Model‐Building with Fractional Polynomials (2008) (54)
- Bootstrap Assessment of the Stability of Multivariable Models (2009) (53)
- Value of sonomorphological criteria of the endometrium in women with postmenopausal bleeding: a multivariate analysis (2002) (50)
- Two Techniques for Investigating Interactions between Treatment and Continuous Covariates in Clinical Trials (2009) (46)
- The practical utility of incorporating model selection uncertainty into prognostic models for survival data (2005) (45)
- On stability issues in deriving multivariable regression models (2015) (45)
- The prognostic effect of histological tumor grade in node-negative breast cancer patients (2004) (42)
- Modelling continuous exposures with a ‘spike’ at zero: A new procedure based on fractional polynomials (2010) (42)
- A new strategy for meta‐analysis of continuous covariates in observational studies (2011) (41)
- Investigating the prediction ability of survival models based on both clinical and omics data: two case studies (2014) (41)
- A randomized comparison of triptorelin and tamoxifen as treatment of progressive ovarian cancer. (1995) (41)
- Modeling the effects of continuous risk factors. (2000) (40)
- Eight-year results of a prospective non-randomised study on therapy of small breast cancer. The German Breast Cancer Study Group (GBSG). (1998) (40)
- The prognostic effect of histological tumour grade in node-negative breast cancer patients (1993) (39)
- Cellular DNA content and survival in advanced ovarian carcinoma (1994) (39)
- Human papillomavirus DNA in cervical carcinoma—correlation with clinical data and influence on prognosis (1994) (38)
- Cross-Validation, Shrinkage and Variable Selection in Linear Regression Revisited (2013) (38)
- Prognostic factors. Confusion caused by bad quality design, analysis and reporting of many studies. (2005) (37)
- Prognostic value of DNA ploidy and S-phase fraction in stage I endometrial carcinoma. (1995) (37)
- CA-125 serum concentrations during the menstrual cycle. (1988) (37)
- Is treatment with interferon-α effective in all patients with metastatic renal carcinoma? A new approach to the investigation of interactions (2004) (35)
- Comparison of procedures to assess non‐linear and time‐varying effects in multivariable models for survival data (2011) (34)
- Interaction of treatment with a continuous variable: simulation study of significance level for several methods of analysis (2013) (33)
- Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles (2017) (33)
- Classification of adnexal tumors by transvaginal color Doppler. (1996) (33)
- Detecting an interaction between treatment and a continuous covariate: A comparison of two approaches (2007) (32)
- Continuous-wave and pulsed Doppler studies of the breast: clinical results and effect of transducer frequency. (1991) (32)
- Effects of Radiotherapy in Early-Stage, Low-Recurrence Risk, Hormone-Sensitive Breast Cancer (2018) (31)
- Evidence-Based Assessment and Application of Prognostic Markers: The Long Way from Single Studies to Meta-Analysis (2006) (31)
- Facilitating harmonized data quality assessments. A data quality framework for observational health research data collections with software implementations in R (2020) (30)
- Interaction of treatment with a continuous variable: simulation study of power for several methods of analysis (2014) (30)
- Long-term prognosis of breast cancer patients with 10 or more positive lymph nodes treated with CMF. (2001) (29)
- On properties of predictors derived with a two-step bootstrap model averaging approach - A simulation study in the linear regression model (2008) (29)
- Quantitative flow measurements for classification of ovarian tumors by transvaginal color Doppler sonography in postmenopausal patients (1994) (29)
- Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients: an update based on 10 years' follow-up. German Breast Cancer Study Group. (2000) (28)
- Validation of existing and development of new prognostic classification schemes in node negative breast cancer (2004) (28)
- Validation of existing and development of new prognostic classification schemes in node negative breast cancer (2004) (27)
- Assessment of breast cancer vascularisation by Doppler ultrasound as a prognostic factor of survival. (2004) (26)
- Differentiation of Benign and Malignant Breast Tumors by Logistic Regression and a Classification Tree using Doppler flow signals (1998) (26)
- Randomized Study Comparing Carboplatin/Cyclophosphamide and Cisplatin/Cyclophosphamide as First-Line Treatment in Patients with Stage III/IV Epithelial Ovarian Cancer and Small Volume Disease☆☆☆ (1997) (26)
- Global, Parameterwise and Joint Shrinkage Factor Estimation (2016) (22)
- Steroid receptors in carcinoma of the breast. Results of immunocytochemical and biochemical determination and their effects on short-term prognosis. (1994) (21)
- Prognostic Factor Studies (2012) (19)
- Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia (2019) (19)
- Modeling Variables With a Spike at Zero: Examples and Practical Recommendations (2017) (19)
- Investigation about a screening step in model selection (2008) (18)
- Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 2 on Triage, Treatment and Follow-up (2019) (17)
- Therapy of small breast cancer - four-year results of a prospective non-randomized study (1995) (17)
- Diagnostic formula for the differentiation of adnexal tumors by transvaginal sonography (1997) (17)
- Modelling to extract more information from clinical trials data: On some roles for the bootstrap (2007) (16)
- Variable Selection and Shrinkage: Comparison of Some Approaches (2001) (16)
- Introduction to statistical simulations in health research (2020) (16)
- Analysing covariates with spike at zero: A modified FP procedure and conceptual issues (2012) (16)
- Co‐expression of M‐CSF transcripts and protein, FMS (M‐CSF receptor) transcripts and protein, and steroid receptor content in adenocarcinomas of the ovary (1994) (16)
- Improving the Prognostic Ability through Better Use of Standard Clinical Data - The Nottingham Prognostic Index as an Example (2016) (16)
- Multivariable fractional polynomial interaction to investigate continuous effect modifiers in a meta-analysis on higher versus lower PEEP for patients with ARDS (2016) (16)
- Investigation on the Improvement of Prediction by Bootstrap Model Averaging (2006) (15)
- The effect of oral contraceptive use on the prognosis of node positive breast cancer patients. (1998) (15)
- Effect of timing of surgery during the menstrual cycle of premenopausal breast cancer patients (1995) (15)
- Simulation Modeling of Cancer Clinical Trials: Application to Omitting Radiotherapy in Low-risk Breast Cancer (2018) (14)
- Differential diagnosis of breast lesions by color Doppler (1995) (14)
- Multivariable model-building with continuous covariates : 1 . Performance measures and simulation design (2011) (14)
- Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node‐positive breast‐cancer patients (2000) (14)
- Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review (2018) (14)
- Estrogen and progesterone receptors in ovarian neoplasms: discrepant results of immunohistochemical and biochemical methods (1991) (14)
- An Experimental Evaluation of Boosting Methods for Classification (2010) (14)
- Intraperitoneal adenovirus-mediated suicide gene therapy in combination with either topotecan or paclitaxel in nude mice with human ovarian cancer (2002) (14)
- Multivariate analysis of flow data in breast lesions and validation in a normal clinical setting. (2010) (13)
- [Therapy of hypopharyngeal cancer. Part IV: Long-term results of transoral laser microsurgery of hypopharyngeal cancer]. (1994) (13)
- Long-Term Follow-Up of Patients in Four Prospective Studies of the German Breast Cancer Study Group (GBSG): A Summary of Key Results (2002) (13)
- Breast preservation versus mastectomy in early breast cancer--1991 update of the GBSG 1--protocol and prognostic factors. The German Breast Cancer Study Group. (1992) (13)
- Timing of breast cancer surgery--some arguments that there is no effect. (1994) (13)
- Quality control review for radiotherapy of small breast cancer: analysis of 708 patients in the GBSG I trial. German Breast Study Group (GBSG). (1993) (13)
- Steroid receptors in ovarian carcinoma: Immunohistochemical determination may lead to new aspects (1993) (12)
- Meta‐analysis of non‐linear exposure‐outcome relationships using individual participant data: A comparison of two methods (2018) (12)
- Information from CTC measurements for metastatic breast cancer prognosis—we should do more than selecting an “optimal cut point” (2010) (12)
- Human papillomavirus DNA in tumor-free regional lymph nodes: a potential prognostic marker in cervical carcinoma. (1996) (11)
- On Statistical Approaches for the Multivariable Analysis of Prognostic Marker Studies (2007) (10)
- Tumor stage and early mortality for surgical resections in lung cancer (2003) (10)
- DNA flow cytometry in node-positive breast cancer. Prognostic value and correlation with morphologic and clinical factors. (1995) (10)
- Stability analysis of an additive spline model for respiratory health data by using knot removal (2009) (9)
- On Fishing for Significance and Statistician’s Degree of Freedom in the Era of Big Molecular Data (2017) (9)
- Prognostic effect of timing of surgery during menstrual cycle in premenopausal breast‐cancer patients (1994) (9)
- CONTINUOUS VARIABLES: TO CATEGORIZE OR TO MODEL? (2010) (9)
- A plea for taking all available clinical information into account when assessing the predictive value of omics data (2019) (8)
- Combining clinical and molecular data in regression prediction models: insights from a simulation study (2019) (8)
- Handling interactions in Stata, especially with continuous predictors (2012) (8)
- REMARK (REporting Recommendations for Tumor MARKer Prognostic Studies) (2014) (8)
- Modeling continuous covariates with a “spike” at zero: Bivariate approaches (2016) (8)
- Prognostic factor research (2019) (8)
- Adding local components to global functions for continuous covariates in multivariable regression modeling (2010) (8)
- The effect of oral contraceptive use on the prognosis of node positive breast cancer patients. German Breast Cancer Study Group. (1998) (7)
- [Analysis of a method for Doppler study of the female breast]. (2008) (7)
- A note on estimating local recurrence rates in clinical trials on the treatment of breast cancer (1998) (7)
- Wiley Series in Probability and Statistics (2008) (7)
- DNA flow cytometry in stage IB and II cervical carcinoma (1995) (7)
- Selection of Variables (2008) (7)
- Use of pretransformation to cope with extreme values in important candidate features (2011) (6)
- Assessment of the extent of unpublished studies in prognostic factor research: a systematic review of p53 immunohistochemistry in bladder cancer as an example (2016) (6)
- Mfpa: Extension of mfp Using the ACD Covariate Transformation for Enhanced Parametric Multivariable Modeling (2016) (6)
- Investigation of continuous effect modifiers in a meta-analysis on higher versus lower PEEP in patients requiring mechanical ventilation - protocol of the ICEM study (2014) (6)
- Estimating the Effect of a Prognostic or Risk Factor after Selection of an " Optimal " Cutpoint (2001) (5)
- A Measure for Assessing Functions of Time-Varying Effects in Survival Analysis (2014) (5)
- Increasing the usefulness of additive spline models by knot removal (2008) (5)
- Modeling exposures with a spike at zero: simulation study and practical application to survival data (2019) (5)
- Review of guidance papers on regression modeling in statistical series of medical journals (2022) (5)
- [Differential breast diagnosis using CW-Doppler ultrasound]. (1990) (5)
- Multivariable Fractional Polynomial Models (2016) (5)
- Exploration of the variability of variable selection based on distances between bootstrap sample results (2019) (5)
- Dose–response modelling for bivariate covariates with and without a spike at zero: theory and application to binary outcomes (2015) (5)
- Re: Reporting recommendations for tumor marker prognostic studies (REMARK) - Reply (2005) (5)
- REporting recommendations for tumor MARKer prognostic studies (REMARK). (2005) (5)
- Detection of influential points as a byproduct of resampling-based variable selection procedures (2017) (4)
- On alcohol consumption and all-cause mortality (2001) (4)
- Randomized study comparing carboplatin/cyclophosphamide and cisplatin/cyclophosphamide as first-line treatment in patients with stage III/IV epithelial ovarian cancer and small volume disease. German Ovarian Cancer Study Group (GOCA). (1997) (4)
- Relationship between epidermal growth factor receptor (EGF-R) and various prognostic factors in human endometrial carcinoma (1991) (4)
- Sonographic Detection of Occult Tumor Extension (1994) (4)
- Handling co-dependence issues in resampling-based variable selection procedures: a simulation study (2018) (4)
- Exaggeration of the prognostic effect of Mammostrat: a consequence of poor reporting? (2013) (4)
- Multivariable model-building with continuous covariates : 2 . Comparison between splines and fractional polynomials (2011) (4)
- Comparison of variable selection procedures and investigation of the role of shrinkage in linear regression-protocol of a simulation study in low-dimensional data (2022) (4)
- [Initial results of the Project of the German Breast Cancer Study Group on "Breast saving therapy of the small breast cancer"]. (1992) (4)
- Fractional Polynomials for One Variable (2008) (4)
- Diagnostic tools and prognostic factors in human breast cancer evaluated by morphological and immunohistochemical methods (1992) (4)
- The use of fractional polynomials to model interactions between treatment and continuous covariates in clinical trials (2002) (3)
- Effect of radiotherapy in addition to 6 cycles CMF in node positive breast cancer patients (1998) (3)
- Guidance for designing and analysing observational studies: The strengthening analytical thinking for observational studies (STRATOS) initiative (2017) (3)
- Doug Altman: Driving critical appraisal and improvements in the quality of methodological and medical research (2020) (3)
- Comment on ‘BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses' (2018) (3)
- Aspekte der statistischen Evaluation neuer Prognosefaktoren: Illustration bei Studien in der Onkologie (1999) (3)
- Bootstrap and Cross-Validation to Assess Complexity of Data-Driven Regression Models (2000) (3)
- Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
- Rhythmic fluctuations of CEA serum levels in breast cancer patients. (1987) (3)
- Structured reporting to improve transparency of analyses in prognostic marker studies (2022) (3)
- Importance of the distinction between quality of methodology and quality of reporting. (2017) (3)
- Methods for Evaluating Medical Tests and Biomarkers (2017) (3)
- Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients (2001) (2)
- On approaches for modelling time-varying effects in survival analysis (2008) (2)
- MODELLING INTERACTIONS WITH CONTINUOUS VARIABLES (2010) (2)
- Color Doppler Flow Assessment of Breast Disease (1994) (2)
- The German Breast Preservation Trial. Concept and first results related to the structural relationship of various prognostic factors (1990) (2)
- Systematic review of education and practical guidance on regression modeling for medical researchers who lack a strong statistical background: Study protocol (2020) (2)
- Treatment of Primary Breast Cancer at the Surgical Unit of the Charité 1984-1998 (2013) (2)
- Updated survival results from the Zebra trial. (2002) (2)
- On the Development and Validation of Classification Schemes in Survival Data (1997) (2)
- Determination of Functional Relationships for Continuous Variables by Using a Multivariable Fractional Polynomial Approach (2002) (2)
- THE IMPORTANCE OF BASIC STATISTICAL PRINCIPLES FOR THE INTERPRETATION OF EPIDEMIOLOGICAL DATA (1997) (2)
- The Multivariable Fractional Polynomial Approach , with Thoughts about Opportunities and Challenges in Big Data (2016) (2)
- Faculty of 1000 evaluation for Reporting performance of prognostic models in cancer: a review. (2011) (1)
- Special Topics Involving Fractional Polynomials (2008) (1)
- Detecting an interaction between treatment and a continuous covariate : a comparison between two approaches (2006) (1)
- Duration of adjuvant chemotherapy for breast cancer: A joint analysis of two randomized trials investigating 3 versus 6 courses of CMF (cyclophosphamide, methotrexate and 5-fluorouracil) (2002) (1)
- [24-hour CA 15/3 serum concentrations in patients with primary and metastasizing breast cancer]. (1987) (1)
- 32 Building multivariable prognostic models: Transformation of the predictors using fractional polynomials (1997) (1)
- Therapy of small breast cancer — comparision between mastectomy and breast preserving therapy (1991) (1)
- Management of Data in Clinical Trials. Eleanor McFadden, Wiley, 1998. No. of pages: xi+210. Price: £50. ISBN 0‐471‐30316‐X (1999) (1)
- Comments on ‘Performance of using multiple stepwise algorithms for variable selection’ by Ryan E. Wiegand, Statistics in Medicine 2010; 29:1647–1659 (2011) (1)
- Investigating treatment-effect modification by a continuous covariate in IPD meta-analysis: an approach using fractional polynomials (2022) (1)
- Some Comparisons of MFP with Splines (2008) (1)
- Comment on: Reporting recommendations for tumor marker prognostic studies (REMARK). Authors' reply (2005) (1)
- Exploration of the variability of variable selection based on distances between bootstrap sample results (2019) (1)
- O-12 Radiation therapy after breast-conserving surgery: randomised trial in patients with low risk of recurrence (2007) (1)
- Faculty Opinions recommendation of Trials in primary care: statistical issues in the design, conduct and evaluation of complex interventions. (2010) (1)
- Pulmonary Function in Coronary Heart Disease and Valve Disease (1988) (0)
- Contents, Vol. 20, 1997 (1997) (0)
- How To Work with MFP (2008) (0)
- A randomized clinical trial evaluating the duration of chemotherapy in patients with primary, node-positive breast cancer (1993) (0)
- Is Aphasia a Significant Prognostic Factor for the Recovery of Function After Ischemic Stroke Causing Hemiparesis? (1989) (0)
- S37.2: Comparison of predictors in the linear regression model: Improvement by bootstrap averaging? (2004) (0)
- Determinants of prognosis after first isolated locoregional recurrence of breast cancer (1998) (0)
- Toward a Comprehensive, Integrated Framework for Advanced Statistical Analyses of Observational Studies (19w5198) (2019) (0)
- Education for Statistics in Practice (2010) (0)
- Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice. (2023) (0)
- Methodological aspects of diagnostic models of atopic dermatitis (1993) (0)
- Response to Katz and Kattan (2006) (0)
- Overinterpretation and misreporting of prognostic factor studies in medical oncology (2016) (0)
- BBS Seminar IPD meta-analysis of treatment-covariate interaction with a continuous predictor (2013) (0)
- University of Birmingham Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? (2017) (0)
- Statistical aspects in the analysis of a breast cancer clinical trial (1991) (0)
- Comparison of 3 versus 6 cycles CMF in node positive breast cancer patients based on 10 years follow-up (1998) (0)
- EVALUATING CLINICAL EVIDENCE: A HANDBOOK FOR MANAGERS. (1996) (0)
- Re: Meta-analysis comparing cisplatin total dose intensity and survival: a critical reappraisal. (1996) (0)
- Faculty Opinions recommendation of Recent developments in meta-analysis. (2009) (0)
- Interaction of treatment with a continuous variable: Comparison of approaches and an IPD meta-analysis to summarize results across several studies (2014) (0)
- S41.3: Modelling time‐varying effects in survival data (2004) (0)
- REporting recommendations for tumor MARKer prognostic studies (REMARK). (2005) (0)
- Use of Resampling Procedures to Investigate Issues of Model Building and Its Stability (2019) (0)
- Investigating interactions in multivariable model-building with continuous covariates (2008) (0)
- Abstract P2-11-01: Effects of radiotherapy on breast cancer outcomes among stage I, low-Recurrence risk, hormone-Sensitive breast cancer: Pooled analysis of individual data from phase III trials (2018) (0)
- Faculty Opinions recommendation of Evaluation of networks of randomized trials. (2009) (0)
- Response to “How to judge a tumor marker” Katz and Kattan (2005) (0)
- Updated survival analyses from the ZEBRA study: goserelin vs CMF in premenopausal women with node-positive breast cancer (2003) (0)
- STRATOS News vol. 1 (2018) (0)
- Investigations on Stability and Overoptimism of Classification Trees by Using Cross-Validation (2001) (0)
- Some Issues with Univariate Fractional Polynomial Models (2008) (0)
- Title : Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania Version : 2 (0)
- Comment on ‘BAG-1 as a biomarker in early breast cancer prognosis: a systematic review with meta-analyses' (2018) (0)
- Faculty Opinions recommendation of Almost all articles on cancer prognostic markers report statistically significant results. (2008) (0)
- Subject Index Vol. 20, 1997 (1997) (0)
- PLASMA TRYPTOPHAN A BIOCHEMICAL MARKER OF SUICIDE BEHAVIOUR (1987) (0)
- Effects of influential points and sample size on the selection and replicability of multivariable fractional polynomial models (2022) (0)
- REMARK guidelines for tumour biomarker study reporting: a remarkable history (2022) (0)
- Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
- Autorenregister Vol. 36, 1996 (2004) (0)
- [Combined evaluation of ovarian tumors with transvaginal B-image and color Doppler ultrasound]. (1996) (0)
- Erratum to: Methods for evaluating medical tests and biomarkers (2017) (0)
- Basic Statistical Principles for the Evaluation of Risk Factors (1994) (0)
- Contents Vol. 36, 2013 (2013) (0)
- Exhuming nonnegative garrote from oblivion using suitable initial estimates- illustration in low and high-dimensional real data (2022) (0)
- Use of Crossvalidation to Assess Diagnostic Classification Schemes of Atopic Dermatitis (1997) (0)
- Overinterpretation and misreporting of prognostic factor studies in oncology: a systematic review (2018) (0)
- [Transvaginal color-coded Doppler ultrasound in ovarian tumors]. (1994) (0)
- 712 Evaluation of Cardiotoxicity via Speckle-Tracking Echocardiography in Patients Treated with Anthracyclines (2015) (0)
- Band 25, Heft 2, April 2002 (2002) (0)
- The influence of categorizing survival time on parameter estimates in a Cox model (2007) (0)
- Statistical models for complex data in clinical and epidemiological research (2020) (0)
- O-3 Long-term results from the ZEBRA trial comparing Goserelin with CMF as adjuvant therapy in premenopausal women (2007) (0)
- Prognostic impact of HER-2/neu gene copy number determination by fluorescence in situ hybridisation (FISH) versus immunohistochemically detected overexpression in node positive primary breast cancer (1998) (0)
- Appendix A: Data and Software Resources (2008) (0)
- Handling Categorical and Continuous Predictors (2008) (0)
- Appendix B: Glossary of Abbreviations (2008) (0)
- Education for biometry in practice (2018) (0)
- [Adjuvant chemotherapy of breast cancer with the CMFV protocol]. (1990) (0)
- Statistical aspects of the development and validation of a diagnostic score (1994) (0)
- Developing a Comprehensive, Integrated Framework for Advanced Statistical Analyses of Observational Studies (2016) (0)
- 14th Annual Meeting Oberrheinische Arbeitsgemeinschaft für Onkologie (OAO). Groupe de Travail des Oncologues du Rhin Supérieur (GTOR), Metz, February 6–7, 1998 (1997) (0)
- Sachregister Vol. 36, 1996 (1996) (0)
- A method for IPD meta-analysis of treatment-covariate interaction with a continuous predictor in randomised trials (2014) (0)
- [Champagne administered by spoon for peritonitis after cesarean section. From the history of obstetrics in Erlangen--data from about 60,000 deliveries in 100 years]. (1996) (0)
- Overinterpretation and misreporting of prognostic factor and biomarker studies in medical oncology. (2017) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Willi Sauerbrei?
Willi Sauerbrei is affiliated with the following schools: